ERBB2 and breast cancer: Prior to quantitative cytotoxicity assays on several cell lines, we decided to investigate whether the (ZHER2:4)2DCS-MMAE conjugate can affect the growth of HER2-positive (HER2+) breast cancer SK-BR-3 cells.